BioCina Resources Hub

Curated insights, technical guides, and industry updates from a global CDMO leader

Filter by:

Featured image for “BioCina Initiates Comprehensive Manufacturing Program for Patrys’ Proprietary Injectable Therapeutic to Alleviate Delirium”

BioCina Initiates Comprehensive Manufacturing Program for Patrys’ Proprietary Injectable Therapeutic to Alleviate Delirium

BioCina Pty Ltd., announced it has initiated a comprehensive CMC (Chemistry, Manufacturing, and Controls) program for the advancement of RLS-2201.…

Featured image for “BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer”

BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer

BioCina, a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dr. Thomas Broudy has been appointed as…

Featured image for “Australia as a Strategic Gateway: The Economic and Regulatory Advantages of Clinical Manufacturing Down Under”

Australia as a Strategic Gateway: The Economic and Regulatory Advantages of Clinical Manufacturing Down Under

Biopharmaceutical companies are under mounting pressure to move faster, spend less, and ensure global compliance all without compromising innovation. This…

Featured image for “BioCina and NovaCina Merger Bolsters Global CDMO Industry”

BioCina and NovaCina Merger Bolsters Global CDMO Industry

Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a strategic merger that will create a powerful brand…

Featured image for “BioCina Expands Perth Facility to Provide Clinical Supplies Services”

BioCina Expands Perth Facility to Provide Clinical Supplies Services

Exciting news from NovaCina! We’ve installed and qualified a new Cytiva SA25 GMP isolator filling line to……

Featured image for “Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine”

Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine

Adelaide, South Australia, October 10, 2024/– BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced…

Featured image for “EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment”

EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

Adelaide, South Australia, September 25, 2024/ — BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO),…

Featured image for “BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx”

BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx

BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx Adelaide, South Australia, June 3, 2024/–…

Featured image for “BioCina and NovaCina Forge Strategic Alliance to Offer Biologics Developers Integrated Drug Substance and Drug Product Solutions”

BioCina and NovaCina Forge Strategic Alliance to Offer Biologics Developers Integrated Drug Substance and Drug Product Solutions

ADELAIDE, South Australia, and PERTH, Western Australia, Feb. 27, 2024 /PRNewswire/ — BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and…

Looking for Something Specific?

If you can't find what you need, our team can provide tailored resources and program-specific information to help move your program forward.

Request Information